Yoganand Chillarige, MPA

Senior Research Manager
Acumen LLC

Disclosure(s): CDC: Author is an employee of Acumen LLC. This study was funded through an inter-agency agreement between CDC and CMS for which Acumen is a contractor.

Poster(s):

• (P-2049) Interim Estimates of Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Outcomes Among Medicare Enrollees with End Stage Renal Disease — United States, September – December 2023
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT